This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kadar, T. Articles by Shapira, S. Search for Related Content PubMed PubMed Citation Articles by Kadar, T. Articles by Shapira, S. Social Bookmarking                         What's this?

Long-Term Study of Brain Lesions Following Soman, in Comparison to DFP and Metrazol Poisoning

Department of Pharmacology, Israel Institute for Biological Research, Ness-Ziona 70450, Israel

G. Cohen

Department of Pharmacology, Israel Institute for Biological Research, Ness-Ziona 70450, Israel

R. Sahar

Department of Pharmacology, Israel Institute for Biological Research, Ness-Ziona 70450, Israel

D. Alkalai

Department of Pharmacology, Israel Institute for Biological Research, Ness-Ziona 70450, Israel

S. Shapira

Department of Pharmacology, Israel Institute for Biological Research, Ness-Ziona 70450, Israel

The long-term histopathological effects of acute lethal (95 µg kg^-1) and sublethal (56 µg kg^-1) doses of soman were studied in rats and were compared to lesions caused by equipotent doses of either another cholinesterase (ChE) inhibitor, DFP (1.8 mg kg^-1), or a non-organophosphorus convulsant, metrazol (100 mg kg^-1). Severe toxic signs were noted following one LD₅₀ dose administration of all the compounds, yet only soman induced brain lesions. Moreover, even when administered at a sublethal dose (0.5 LD₅₀), soman induced some histological changes without any clinical signs of intoxication.

Soman-induced brain lesions were assessed quantitatively using a computerized image analyser. The analysis was carried out for up to 3 months following administration, and a dynamic pattern of pathology was shown. The cortical thickness and area of CA1 and CA3 cells declined significantly as early as 1 week post-exposure. No pathological findings were detected following DFP and metrazol administration. It is therefore suggested that brain lesions are not common for all ChE inhibitors and that convulsions per se are not the only factor leading to brain damage following the administration of soman. The degenerative process (found also with the sublethal dose of soman) might be due to a secondary effect, unrelated to soman's clinical toxicity, but leading to long-term brain injuries.

Human & Experimental Toxicology, Vol. 11, No. 6, 517-523 (1992)
DOI: 10.1177/096032719201100613


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Tryphonas, J. P. Veinot, and J. G. Clement Early Histopathologic and Ultrastructural Changes in the Heart of Sprague-Dawley Rats Following Administration of Soman Toxicol Pathol, March 1, 1996; 24(2): 190 - 198. [Abstract] [PDF]

				L. Tryphonas and J. G. Clement Histomorphogenesis of Soman-Induced Encephalocardiomyopathy in Sprague-Dawley Rats Toxicol Pathol, May 1, 1995; 23(3): 393 - 409. [Abstract] [PDF]